Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Oct. 03, 2026	Sep. 27, 2025
Cash flows from operating activities:
Net income	$ 282,172	$ 51,745
Non-cash and other reconciling items:
Depreciation, Depletion and Amortization, Nonproduction	19,249	16,839
Amortization of Operating Lease Assets	16,860	13,934
Deferred income taxes	13,700	(5,983)
Stock-based compensation	18,888	9,724
Other, net	7,016	(13,324)
Changes in (net of effects from businesses acquired and divested):
Receivables	(893,321)	(192,583)
Inventories	(2,121,749)	(216,326)
Accounts payable	1,810,176	218,297
Accrued expenses and other, net	4,601	(26,907)
Net cash flows used for operating activities	(842,408)	(144,584)
Cash flows from financing activities:
Issuance of convertible notes, net of issuance costs	545,551	633,750
Repayments under accounts receivable securitization, net	(474,600)	(299,400)
Borrowings (repayments) under senior unsecured credit facility, net	648,897	(290,861)
Borrowings (repayments) under bank credit facilities and other debt, net	(27,686)	10,352
Borrowings of term loans	375,000	266,932
Repayments of term loans	(88,946)
Repurchases of common stock		(138,308)
Dividends paid on common stock	(30,424)	(28,464)
Other, net	2,979	1,137
Net cash flows provided by financing activities	950,771	155,138
Cash flows from investing activities:
Purchases of property, plant and equipment	(24,262)	(24,589)
Other, net	822	80
Net cash flows used for investing activities	(23,440)	(24,509)
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation	(3,539)	(3,008)
Cash and cash equivalents:
Increase (Decrease)	81,384	(16,963)
Cash and cash equivalents at beginning of year	155,396	192,428
Cash and cash equivalents at end of year	$ 236,780	$ 175,465